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Background: Point mutations or genomic deletions of FOXF1 result in a lethal developmental lung disease Alveolar
Capillary Dysplasia with Misalignment of Pulmonary Veins. However, the clinical consequences of the constitutively
increased dosage of FOXF1 are unknown.
Methods: Copy-number variations and their parental origin were identified using a combination of array CGH,
long-range PCR, DNA sequencing, and microsatellite analyses. Minisatellite sequences across different species were
compared using a gready clustering algorithm and genome-wide analysis of the distribution of minisatellite sequences
was performed using R statistical software.
Results: We report four unrelated families with 16q24.1 duplications encompassing entire FOXF1. In a 4-year-old boy
with speech delay and a caf?-au-lait macule, we identified an ~15 kb 16q24.1 duplication inherited from the reportedly
healthy father, in addition to a de novo ~1.09 Mb mosaic 17q11.2 NF1 deletion. In a 13-year-old patient with autism and
mood disorder, we found an ~0.3 Mb duplication harboring FOXF1 and an ~0.5 Mb 16q23.3 duplication, both inherited
from the father with bipolar disorder. In a 47-year old patient with pyloric stenosis, mesenterium commune, and aplasia
of the appendix, we identified an ~0.4 Mb duplication in 16q24.1 encompassing 16 genes including FOXF1. The patient
transmitted the duplication to her daughter, who presented with similar symptoms. In a fourth patient with speech
and motor delay, and borderline intellectual disability, we identified an ~1.7 Mb FOXF1 duplication adjacent to a large
minisatellite. This duplication has a complex structure and arose de novo on the maternal chromosome, likely as a result
of a DNA replication error initiated by the adjacent large tandem repeat. Using bioinformatic and array CGH analyses of
the minisatellite, we found a large variation of its size in several different species and individuals, demonstrating both its
evolutionarily instability and population polymorphism.
Conclusions: Our data indicate that constitutional duplication of FOXF1 in humans is not associated with any pediatric
lung abnormalities. We propose that patients with gut malrotation, pyloric or duodenal stenosis, and gall bladder
agenesis should be tested for FOXF1 alterations. We suggest that instability of minisatellites greater than 1 kb can lead
to structural variation due to DNA replication errors.
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Heterozygous point mutations and genomic deletions
involving the dosage-sensitive FOXF1 gene on chromo-
some 16q24.1 have been reported as causative in patients
with a rare, neonatally-lethal developmental lung disorder
Alveolar Capillary Dysplasia with Misalignment of
Pulmonary Veins (ACDMPV; OMIM 265380) [1-5].
The majority of patients with ACDMPV also have
extra-pulmonary anomalies of the gastrointestinal,
cardiovascular, or genitourinary systems. In a number
of ACDMPV patients negative for mutation and dele-
tion in FOXF1, we identified overlapping genomic
deletions mapping upstream of FOXF1. These deletions
enabled us to define an ~60 kb noncoding, evolutionarily-
conserved, and differentially-methylated cis-regulatory en-
hancer region that maps ~272 kb upstream of FOXF1 and
harbors lung-specific long non-coding RNA (lncRNA)
genes [6,7]. Recently, we demonstrated that the FOXF1
locus in humans is incompletely paternally-imprinted in
the lungs, and that the imprinting likely involves these
lncRNAs [6,8]. Moreover, the antisense lncRNA gene,
FENDRR, located 5 kb upstream of FOXF1, was found to
associate with the polycomb repressive complex (PRC)2
and negatively regulate FOXF1 expression [9].
Foxf1-/- mice die by embryonic day (e) 8.5 due to
vascular abnormalities that stem from defects in mesoder-
mal differentiation and cell adhesion [10]. Approximately
50-90% of the heterozygous Foxf1+/- mice, depending on
their genetic background, die neonatally due to respiratory
failure [11,12]. Endothelium specific homozygous knock-
out of Foxf1 using Tie2-cre and Pdgfb-CreER leads to
embryonic lethality around e13.5-e16.5 due to vascular
abnormalities in the lung, placenta and yolk sac [13].
Endothelial specific deletion of Foxf1 causes decreased
expression of endothelial genes critical for vascular devel-
opment, including VEGF receptors Flt1 and Flk1, Pdgfb,
Pecam1, CD34, integrin β3, ephrin B2, Tie2 and Fendrr.
Interestingly, homozygous loss of Fendrr in mice was
shown to be either embryonic lethal due to heart and body
wall defects [14], or perinatal lethal due to multiple defects
in lung, heart, or gastrointestinal tract [15].
Previous studies have shown FOXF1 to be epigeneti-
cally inactivated in breast cancer, suggesting its potential
role as a tumor suppressor gene [16]. Common variants
mapping on chromosome 16q24.1 close to FOXF1 have
also been associated with susceptibility to Barrett ? s
esophagus in genome-wide association studies [17,18].
Up-regulation of FOXF1 has been reported in breast
cancer [19], rhabdomyosarcoma [20], and in colorectal
adenocarcinomas [21]. However, the clinical conse-
quences of constitutively increased dosage of FOXF1
remain unknown.
Variable Number Tandem Repeats (VNTRs) with repeat
units less than nine nucleotides (nt) are referred to asmicrosatellites, those with repeat units between 10 and
100 nt are defined as minisatellites and those with
repeat units greater than 100 nt are termed macrosatel-
lites or megasatellites. VNTRs are extremely unstable,
with mutation rates 10-100,000 times higher than non-
repeat sequences. They tend to be highly polymorphic,
expanding or contracting due to DNA strand replica-
tion or recombination slippage [22,23].
Using chromosomal microarray analysis, we identified
and molecularly characterized overlapping 16q24.1 dupli-
cations harboring entire FOXF1 in four unrelated families.
In addition, we describe an evolutionarily unstable large
minisatellite on chromosome 16q24.1, likely responsible
for the formation of one of these duplications.
Methods
Subject recruitment
Patients 1 and 2 were referred for clinical chromosomal
microarray testing in the Medical Genetics Laboratories
(MGL) at Baylor College of Medicine (BCM). Patient 3 was
referred for genetic counseling to the Medical Genetics
Center, Munich, Germany. Patient 4 was reported in
Decipher (265898) and was referred for clinical chromo-
somal microarray testing at the Saint Vincent de Paul
Catholic Hospitals Association of Lille, Free Faculty of
Medicine, Lille, France. The twelve 16q24.1 non-duplicated
control samples were obtained from clinical diagnostic test-
ing at MGL or ACDMPV research study at BCM.
Patients
Patient 1 is a 4 2/12 year old boy, the third child of a
non-consanguineous 20-year-old mother and 22-year
old father. Maternal complications prior to delivery
included placenta previa. He was born at term via spon-
taneous vaginal delivery with birth weight of 3.2 kg. He
sat unassisted at 5 months and began walking at 9
months. At the age of 28 months, the proband ? s height
was 93 cm (72nd percentile), weight was 14.5 kg (78th
percentile), and head circumference was 29.5 cm (44th
percentile). He has mildly dysmorphic facial features,
with a broad forehead, sparse eyebrows, mildly low-set
ears, and nasal features with small alae, broad tip and
broad bridge. He has brachydactyly of fingers and toes.
There is one caf?-au-lait macule on his left flank. He has
speech delay, is very limited in the number of words
used, and was found to be anxious, hyperactive, unco-
operative, aggressive, and impulsive. He tends to sweat a
lot, especially at night, and has bedwetting. Every two to
three weeks he complains of abdominal pain and feels
nauseous, but does not vomit. Pulmonary findings are
normal on physical examination, with the lungs clear to
auscultation bilaterally without wheezes, rhonchi, or
rales. He has had numerous viral upper respiratory
infections and was hospitalized around 18 months of age
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edly in good health and have had no learning, speech, or
lung problems. Paternal grandparental samples were not
available.
Patient 2 is a 13-year-old boy, who based on Diagnos-
tic and Statistical Manual ? Fifth edition (DSM-V) was di-
agnosed with autism, unspecified mood and anxiety
disorder, pervasive developmental disorder not otherwise
specified and emotional disorder. At the age of 12 years,
his height was 141.5 cm (12th percentile), weight was
32.95 kg (10th percentile), and head circumference was
52.5 cm (24th percentile). He is extremely aggressive and
has poor social skills. He makes poor eye contact and
has fine motor skill delays. There was no evidence of
any lung abnormalities except for a remote history of
asthma. His father was diagnosed with bipolar disorder.
Patient 3 is a 47-year-old female patient, who at the
age of 2 years presented with recurrent vomiting and was
subsequently diagnosed with pyloric stenosis, mesenter-
ium commune, and aplasia of the appendix. Her height
was 168 cm (49th percentile), weight was 58 kg (47th
percentile), and head circumference was 56 cm (71st
percentile). Psychomotor development was normal. At
the age of 34 years, she had a postpartum iliofemoral deep
vein thrombosis on the left side with pulmonary embolism.
Factor V Leiden mutation, Prothrombin G20210A muta-
tion, antithrombin deficiency, protein C deficiency and
protein S deficiency were excluded. At the age of 42 years,
the patient was diagnosed with multiple sclerosis. Her 13-
year-old daughter presented with pyloric stenosis with
bowel malrotation, aplasia of the caecum and appendix,
mesenterium commune, gastroesophageal reflux disease,
as well as persistent foramen ovale, unilateral inguinal her-
nia, and immature hip development. Her height was 162
cm (53rd percentile), weight was 49 kg (42nd percentile),
and head circumference was 55 cm (73rd percentile).
Dumping syndrome, relative short bowel syndrome, fail-
ure to thrive, and dystrophy were noted. Psychomotor
development was normal. There was no evidence for
any lung abnormalities in the two patients. Patient 3 ? s
father presented with hematemesis and anemia in in-
fancy. Laparotomy at the age of 6 years revealed pyloric
stenosis, bowel malrotation, mesenterium commune,
and aplasia of the caecum and appendix. In childhood, a
caput medusa was noted, and at the age of 18 years,
venous ulcers of the legs were observed. Before the age
of 50, the father had several iliofemoral deep venous
thromboses and inferior vena cava atresia was sus-
pected. At the age of 34 years, a Billroth? s operation II
was performed because of a hemorrhagic duodenal
ulcer. He was diagnosed with iron-deficiency anemia,
protein S deficiency, activated protein C resistance, and
renal insufficiency. The father ? s DNA was not available
for testing.Patient 4 is a 10 1/12-year-old boy born to healthy and
non-consanguineous 23 and 25 year-old parents. His
height, weight, and head circumference were 135.5 cm
(between the 25th and 50thpercentile), 29.3 kg (between
the 25th and 50th percentile), and 52 cm (between the 10th
and 25th percentile), respectively. During the pregnancy,
he was diagnosed with a club foot, which was surgically
corrected. He presented with speech delay, motor delay,
and borderline intellectual disability (ID). No respiratory
or cardiac defects were observed. Pedigrees of families 2
and 3 are shown in Additional file 1: Figure S1.
DNA isolation
Genomic DNA was extracted from peripheral blood
via the Puregene DNA isolation kit (Gentra System,
Minneapolis, MN, USA) (patients 1 and 2), FlexiGene
DNA Kit (Qiagen, Valencia, CA) (patient 3) and QIAamp
DNA mini kit (Qiagen, Valencia, CA) (patient 4).
Array CGH analysis
Chromosomal microarray analysis (CMA) in patients 1
and 2 were performed using array CGH (aCGH) with
custom-designed exon targeted aCGH oligonucleotide mi-
croarrays V8.1.1 OLIGO, 180K and V9.1.1 OLIGO, 400K,
respectively, designed by the MGL at BCM (http://www.
bcm.edu/geneticlabs/) and manufactured by Agilent
Technology (Santa Clara, CA, USA) as described [24]. In
patient 3, aCGH analysis was performed using an Oli-
gonucleotide array (Cytochip v1.0 180K, BlueGnome,
Cambridge, GRCh37, Ensembl Release 70) and in
patient 3 ? s daughter, aCGH analysis was done using
Illumina SNP-Array (Infinium? CytoSNP-850K; GRCh37).
aCGH in patient 4 was performed using a 8 ? 60K micro-
array (Agilent Technology). Fine duplication mapping
was performed in patient 1 using aCGH with a custom-
designed 16q24.1-specific 720K microarray covering
2-Mb regions flanking FOXF1 [Roche-NimbleGen
(Madison, WI, USA)] as described [25], and in patients
2 and 4 using a custom-designed 16q24.1 region-
specific 4 ? 180K microarray (Agilent Technology), as
described [6].
FISH analysis
Confirmatory fluorescence in situ hybridization (FISH)
analyses were performed using the standard procedures.
Long-range PCR and DNA sequence analysis
The junction fragments of the duplications were ampli-
fied using long-range PCR with Takara LA Taq Polymer-
ase (TaKaRa Bio USA, Madison, WI, USA) according to
the manufacturer ? s instructions. Primers were designed
using Primer3 software (http://frodo.wi.mit.edu/primer3/),
at the apparent head-to-tail duplication boundaries
inferred from the 16q24.1 custom-designed array CGH
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gel, purified with ExoSAP-IT (USB, Cleveland, OH,
USA) to remove unconsumed dNTPs and primers, and
directly sequenced via Sanger method (Lone Star Labs,
Houston, TX, USA).
Microsatellite analysis
Microsatellite markers D16S539, D16S488, D16S486,
D16S520, and D16S3074 for parental studies were PCR
amplified and analyzed by capillary electrophoresis
(SeqWright, Houston, TX), followed by analysis using
the GeneMapper software (Applied Biosystems, Foster
City, CA).
Bioinformatic and in silico DNA sequence analyses
Genomic sequences determined based on oligonucleotide
coordinates from aCGH experiments were downloaded
from the UCSC genome browser (NCBI build 37/hg19,
http://genome.ucsc.edu) and assembled using Sequencher
4.8 software (Gene Codes Corporation, Ann Arbor, MI,
USA). Interspersed repeat sequences were identified using
RepeatMasker (http://www.repeatmasker.org).
To determine the occurrence of polymorphism in the
minisatellite region in the general population, the Data-
base of Genomic Variants: Structural Variation track in
the UCSC genome browser was used. Orthologous VNTR
sequences to the minisatellite sequence in other genomes
were obtained using the convert and blat functions in the
UCSC genome browser.
To compare and visualize syntenic sequences among
different organisms, main repeated motifs were extracted
and subjected to pairwise alignment. Repeats composing
each sequence were aligned to form one set consisting
of all existing motifs among the considered species. The
resulting set was clustered into several groups using the
gready clusterization algorithm: the most numerous mo-
tifs were assumed to be centers, while number of differ-
ences was assumed to be metric. One cluster contains
motifs that differ from the center-motif with at most
four point mutations and four point deletions.
Locations and sizes of VNTRs in the human genome,
identified by Tandem Repeats Finder (TRF: http://tandem.
bu.edu/trf/trf.submit.options.html) were downloaded from
the Simple Tandem Repeats track in the UCSC genome
browser [26]. Distances of VNTRs from the nearest
centromere and telomere were calculated using the R
statistical program (http://cran.r-project.org).
Results
Array CGH, FISH, Long-range PCR and DNA sequence
analyses
The 16q24.1 duplications involving FOXF1 in patients
1-4 are shown in Figure 1.Family 1
In patient 1, CMA with V8.1.1 OLIGO revealed a 4-
109 kb duplication on chromosome 16q24.1 involving
FOXF1 and an ~1.09 Mb mosaic deletion of the NF1
region on chromosome 17q11.2. The 16q24.1 duplica-
tion was also found by CMA in the patient ? s father.
NF1 deletions are classified into type I caused by non-
allelic homologous recombination (NAHR) during
meiosis and type II arising from NAHR during mitosis
and associated with a high frequency of somatic mosai-
cism [27,28]. Unfortunately, the resolution of our clinical
array did not allow for distinguishing between these two
kinds of deletions. Custom-designed high-resolution
region-specific aCGH analyses demonstrated that the
16q24.1 duplication is ~15 kb in size (Figure 2a). FISH
analysis in patient 1 with the BAC clone RP11-142O6
showed that the NF1 deletion in 17q11.2 is mosaic and
present in 37% of blood cells examined. Using long-range
PCR (LR-PCR) with primers F1 and R1 (Additional file 1:
Table S1), the proximal breakpoint of the 16q24.1 duplica-
tion was mapped at chr16:86,539,970-86,539,977 (hg19)
and the distal breakpoint was mapped at chr16:86,555,
608-86,555,615, defining a 15,645 bp tandem head-to-tail
duplication. The duplication harbors the entire FOXF1
gene, its promoter, and exon 1 of the lncRNA FENDRR.
DNA sequence analysis of the junction fragment revealed
8 bp GTGGTCAG microhomology (Figure 2b). The
distal breakpoint is located within a SINE/MIR repeti-
tive element and the proximal breakpoint within a
unique sequence. Schematic representation of the strat-
egy used to amplify the duplication breakpoint junction
fragment is shown in Figure 2c.
Family 2
In patient 2, CMA identified a copy-number gain of
chromosome band 16q23.3 spanning 505-592 kb followed
by another copy-number gain of the nearby 16q24.1
region spanning 265-327 kb and harboring FOXF1. Both
duplications were inherited from the father. Custom-
designed high-resolution aCGH analyses refined the
duplication coordinates to chr16:82,215,062-82,728,565
(0.51 Mb; 16q23.3), involving an upstream portion of
CDH13 and chr16:86,286,094-86,714,315 (0.43 Mb;
16q24.1), harboring entire FOX gene cluster with FOXF1,
FOXC2, and FOXL1. Additionally, custom-designed high-
resolution aCGH analyses identified a third ~52 kb duplica-
tion at 16q24.2 (chr16:87,510,166-87,562,249) (Figure 3a).
Family 3
In patient 3, CMA identified a 417 kb copy-number gain of
chromosome band 16q24.1 (chr16:86,211,060-86,628,524),
encompassing 16 genes, including FOXF1 (Additional
file 1: Figure S2). G-banded chromosomal analysis was
normal. Array CGH analysis in patient 3 ? s daughter
Figure 1 Schematic representation of the 16q24.1 duplications in patients 1-4. Genomic coordinates correspond to hg19 build of the
human genome. Blue bars represent duplications. The distant 60 kb cis-regulatory region mapping 272 kb upstream of FOXF1 is shown in orange
and the minisatellite adjacent to the duplication in patient 4 is shown in red.
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252-86,640,349); differences in coordinates are due to a
different array platform (Figure 3b). Using LR-PCR with
primers F3 and R3 (Additional file 1: Table S1), the
proximal breakpoint of the 16q24.1 duplication was
mapped at chr16:86,194,788-86,194,790 and the distal
breakpoint at chr16:86,642,276-86,642,278, defining a(a)
(b)
Figure 2 Results of aCGH and DNA sequence analyses in patient 1. (a
showing duplication on chromosome 16q24.1. (b) Chromatogram of the DNA
GTGGTCAG. (c) Schematic representation of the strategy used to amplify
not amplified using this approach with the outward facing primers.447,488 bp tandem head-to-tail duplication (Figure 3c).
DNA sequence analysis of the junction fragment re-
vealed 3 bp AGA microhomology (Figure 3d).
Family 4
In patient 4, 8 ? 60K microarray revealed a 1.65-1.80 Mb
16q24.1 duplication. Our customized array enabled(c)
) aCGH plot with the custom-designed NimbleGen 720K microarray
sequence of the junction fragment showing the 8 bp microhomology




Figure 3 Results of aCGH and DNA sequence analyses in patients 2 and 3. (a) aCGH plot obtained using 4x180K microarray (Agilent) in
patient 2 shows three duplicated regions in 16q23.3, 16q24.1, and 16q24.2. (b) aCGH plot from Illumina SNP-Array (Infinium? CytoSNP-850K
showing duplication on chromosome 16q24.1 in patient 3 ? s daughter. (c) Duplication junction fragment visualized on 1% agarose gel in the
proband (P) and her daughter (D), but absent in the control DNA (C). (d) Chromatogram of the DNA sequence of the junction fragment
showing the 3 bp AGA microhomology.
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447,996-87,167,963, adjacent and distal to a large minisa-
tellite (chr16:85,437,712-85,446,335; 8.6 kb) (Figure 4a, b).
FISH analysis with the BAC clone RP11-514D23 con-
firmed the 16q24.1 duplication and excluded an inser-
tional translocation (Figure 4c).
The duplication breakpoints were mapped using
LR-PCR with primers F4 and R4 (Figure 4d, Additional
file 1: Table S1). Sequence analysis of the breakpoint
junction fragment revealed additional complexity, in-
cluding truncated segments of the minisatellite sequence
(chr16:85,437,697-85,446,384), an 8 bp insertion, and two
other junctions with microhomologies (Additional file 1:
Figure S3). Due to the highly repetitive nature of theminisatellite, it was not possible to sequence the break-
points located within it.
Analysis of non-human primates
LR-PCR applied across the tandem repeats in Chimp
(Pan troglodytes) and Rhesus (Macaca mulatta) genomes
revealed the evolutionarily polymorphic nature of the
repeat (Additional file 1: Figure S4).
Microsatellite analysis
Microsatellite analysis in patient 4 was informative for
markers D16S486, D16S520, and D16S3074 and showed
that the duplication arose on the maternal chromosome





Figure 4 Results of aCGH and DNA sequence analyses in patient 4. (a, b) aCGH plot (4x180k Agilent microarray) showing the duplicated
region in patient 3 in chromosome 16q24.1. (c) Result of FISH analysis showing the 16q24.1 duplication in the proband. (d) Duplication junction
fragment visualized on 1% agarose gel in the proband (P), but absent in father (F), mother (M), and control DNA (C). (e) A proposed model of
duplication formation mediated by the adjacent unstable minisatellite: 1, 2, and 3 represent template switches with 8 bp insertion (1) and
microhomologies (2 and 3). Asterix (*) represents the initial DNA replication slippage event that might have triggered the formation of the
described complex genomic rearrangement. Red boxes represent the MLT1D ERVL-MaLR repeat sequences flanking the minisatellite. Green
and yellow boxes represent triplicated sequences.
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In the reference human genome, the large minisatellite is
8,688 kb in size, consisting of imperfect repeats of 33 bp
sequence CAGGGCCCCCCGGATAATCCTCACTGTT
ACACT and is flanked by MLT1D ERVL-MaLR repeat
sequences. Comparison of the aCGH results for this
region in patient 4 with control samples run on high-
resolution 16q24.1 arrays revealed the polymorphic na-
ture of this tandem repeat (Figure 5, Additional file 1:
Figure S6). In addition, several variants of this region
are reported in the Database of Genomic Variants
(DGV) (Additional file 1: Figure S7). Use of convert and
blat functions in the UCSC genome browser showed the
presence of orthologous VNTRs in several genomesTable 1 Fragment analysis for microsatellite markers on 16q2






Informative alleles inherited from the mother are shown in bold.across species (Table 2, Figure 6). Of note, in a few species,
more than one homologous non-syntenic loci were identi-
fied, further suggesting their evolutionary instability.
Genome-wide bioinformatics analyses showed that in
contrast to VNTRs shorter than 1 kb, minisatellites longer
than 1 kb cluster at pericentromeric and subtelomeric
regions (Additional file 1: Figure S8). The distribution of
VNTRs greater than 1 kb, 3 kb, and 5 kb in size across all
chromosomes is shown in Additional file 1: Figure S9.
Discussion
In humans, FOXF1 expression is restricted to the fetal
and adult lungs, prostate, and placenta. Unfortunately,
we do not have RNA samples from these organs to4.1 in patient 4 and his unaffected parents






Figure 5 High-resolution custom-designed region-specific Agilent CGH microarray analyses of the studied minisatellite in 16q24.1.
aCGH plot for patient 4 and 6 non-duplicated control samples run on 4x180k 16q24.1-specific Agilent microarray. Due to the repetitive nature of
the minisatellite, contraction or expansion of the minisatellite shows decrease or increase in log ratios for all oligo probes in this region.
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Table 2 Location of orthologous sequences to the 8.6 kb minisatellite across species
Species Orthologous genomic coordinates Other genomic locations Genome build
Human chr16:85,437,697-85,446,384 (8688 bp) N/A hg19
Chimp chr16(+):85,057,404-85,058,000 (597 bp) chr6(−):171,902,631-171,903,434 (804 bp) CSAC 2.1.4/panTro4
chr16(−):87,565,917-87,566,290 (374 bp)
Gorilla chr16(+):75,975,460-75,975,529 (70 bp) chr7(+):156,341,820-156,342,473 (654 bp) gorGor3.1/gorGor3
Orangutan chr16(+):73,141,772-73,142,390 (619 bp) chr1(−):12,527,885-12,528,916 (1032 bp) WUGSC 2.0.2/ponAbe2
Gibbon chr2(+):158,448,609-158,449,280 (672 bp) chr17(−):95,524,509-95,526,825 (2317 bp) GGSC Nleu3.0/nomLeu3
chr20(−):83,814,471-83,814,741 (271 bp)
Rhesus chr20(+):83,708,139-83,710,782 (2644 bp) N/A BGI CR_1.0/rheMac3
Cow chr18(+):10,576,131-10.576,179 (49 bp) N/A Baylor Btau_4.6.1/bosTau7
Dog chr5(+):67,222,084-67,222,093 (10 bp) chr28(−):35,919,958-35,920,624 (667 bp) Broad CanFam3.1/canFam3
Rat chr14(+):3,644,385-3,645,161 (777 bp) chr8(−):60,446,61-60,465,11 (1851 bp) RGSC 5.0/rn5
chr12(+):82,176,55-82,180,67 (413 bp)
Mouse chr2(+):167,074,771-167,075,545 (775 bp) chr3(+):79,000,591-79,000,853 (263 bp) GRCm38/mm10
chr3(−):144,489,926-144,491,349 (1424 bp)
chr10(−):121,578,768-121,580,330 (1563 bp)
Zebra fish chr16(+):8,911,924-8,912,616 (693 bp) chr4(+):44,314,003-44,315,463 (1461 bp) Zv9/danRer7
chr8(+):41,186,318-41,186,865 (548 bp)
chr15(−):11,992,633-11,992,908 (276 bp)
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tients. Hence, to determine whether FOXF1 could be
functionally over-expressed in the patients, we studied
the involvement of its upstream regulatory elements in
the duplicated segments, as well as their parental origin,
given the incomplete paternal genomic imprinting of
FOXF1 in the human lungs [6,7].
Genomic duplications excluding regulatory elements
of dosage-sensitive genes have been proposed to lead to
inefficient transcription of the extra gene copy and lack
of functional consequences. Amor et al. [29] reported
an ~88 kb duplication at 14q12, encompassing the
dosage-sensitive FOXG1 gene in a father-son pair with
isolated hemifacial microsomia. Neither the son nor theFigure 6 Cross-species visualization of syntenic sequences of the 8.6
motifs among different species and their conservation. Repeat sequences a
particular group of motifs. The descending intensity of the color used to co
from the motif corresponding to that color (mutational and deleterious differe
To increase the clarity of the figure, the human sequence was shortened to ~
insertional translocation sequences (Table 2).father exhibited ID or epilepsy. The authors questioned
the pathogenicity of the increased dosage of FOXG1.
However, this duplication did not include the distant
cis-regulatory elements of FOXG1 [30-33]. Moreover, a
7.4-kb cis-regulatory deletion disrupting conserved non-
coding sequences and their interaction with the promoter
of another FOX gene, FOXL2, mapping more than 280 kb
apart, has been described as pathogenic for blepharophi-
mosis, ptosis, and epicanthus inversus (BPES; OMIM
110100) [34]. This suggests that the presence of long-range
regulatory elements could be a more general phenomenon
common to the forkhead family FOX genes and highlights
the importance of determining the exact location of the
duplication breakpoints.kb minisatellite in 16q24.1. The figure presents the variation of
re represented as a row of multicolor strips and each strip maps to a
de the particular motif indicates the increasing number of differences
nces are represented by upper and lower part of the strip, respectively).
4.1 kb, and the rat and dog sequences are represented by one of the
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FOXF1 is not duplicated. The duplicated exon 1 and part
of the 1st intron of the FENDRR transcript is likely non-
functional (Figure 2a), leaving the duplicated copy of
FOXF1 devoid of its distant upstream cis-regulatory elem-
ent which maps 272 kb upstream (chr16:86,212,040?
86,271,915) [6,7]. Additionally, given the fact that the
duplication is inherited from the father, the increase of
FOXF1 dosage in patient 1 is probably minimal, if any.
Similarly, the FOXF1 duplication in patient 2 does not
encompass the distant upstream cis-enhancer, and is pa-
ternally inherited. Hence, the increase in the expression
level of FOXF1 in patient 2 may also be minor. Conversely,
the lung-specific enhancer region is duplicated in patients
3 and 4. However given the similarity in symptoms be-
tween patient 3 and her father, the duplication in patient
3 is likely paternally inherited and, the increase of FOXF1
expression in patient 3 ? s lungs is likely minimal. In
contrast, as the duplication in patient 3 ? s daughter and
patient 4 arose on the maternal chromosome, the dupli-
cated FOXF1 copy in these patients is likely functional
and associated with an increase of FOXF1 expression
in the lungs.
Along with mild dysmorphic features, patient 1 has
one caf?-au-lait macule on his left flank and speech
delay, typical features of Neurofibromatosis type 1 (NF1;
OMIM 162200). Hence, speech delay and other abnor-
malities in the proband likely result from the NF1 dele-
tion [35] rather than from the FOXF1 duplication. This
notion is further supported by the fact that the father
with isolated FOXF1 duplication was reportedly healthy.
In addition to the FOXF1 duplication on 16q24.1,
patient 2 has two duplications on 16q23.3 and 16q24.2.
The 16q23.3 duplication is also inherited from the father
with bipolar disorder, suggesting that genes other than
FOXF1 may be responsible for the patient ? s autistic and
emotional disorders.
Recently, a patient harboring a complex de novo
duplication-triplication rearrangement in 16q24.1-q24.3
was reported [36]. The patient presented with severe
psychomotor disability, numerous dysmorphic features,
and congenital malformations, including gut malrotation
and gall bladder agenesis. The phenotype in the patient
was attributed to the increased dosage of FOXF1, FOXC2,
ANKRD11, SPG7, and FANCA in the duplicated/tripli-
cated regions. Segregation of gastrointestinal abnormalities
with FOXF1 duplication in family 3 indicates that FOXF1
is incompletely paternally imprinted only in the human
lungs [6] and that the gastrointestinal symptoms in this
family may be due to overexpression of FOXF1 in the
intestine.
Interestingly, maternal uniparental disomy of chromo-
some 16 usually associated with mosaic trisomy 16, and
thus resulting in even higher dosage of FOXF1 is associatedwith pulmonary hypoplasia, congenital heart defects,
tracheosophageal fistula, gut malrotation, and renal agene-
sis in addition to intrauterine growth restriction [37],
suggesting FOXF1 expression higher than that in consti-
tutional duplications may influence development of or-
gans typically affected in patients with ACDMPV.
The presence of ID and speech delay in patient 4 may
result from the duplication of other genes in the duplicated
segment on 16q24.1. This notion is further supported by
another Decipher patient 265650 with a de novo ~0.26 Mb
duplication at chr16:85,678,461-85,942,847 (leaving FOXF1
intact) and presenting with ID and delayed speech and
language development. This duplication involves the
C16orf74, COX4I1, EMC8, GINS2, GSE1, and IRF8
genes that are also duplicated in patient 4. The absence
of any lung defects in all four patients suggests that
constitutional duplication of FOXF1 is likely not patho-
genic in the human lungs.
Interestingly, the duplication in patient 4 mapping distal
and adjacent to a large minisatellite contains in its junc-
tion fragment, truncated segments of this minisatellite.
We found this minisatellite is highly polymorphic in the
general population, with many deletions and duplications
reported in DGV as well as in several control DNA sam-
ples analyzed on our customized high-resolution 16q24.1
CGH microarrays (Figure 5), indicating that it contracts
and expands. The orthologous VNTRs of this minisatellite
in several species are much shorter and range from 597 bp
in Chimp to 2,644 bp in Rhesus (Figure 6, Table 2),
demonstrating its high instability during the evolution
of the human genome. Amplification of this region in
chimp and Rhesus genomes showed that, similar to
human genome, this VNTR is polymorphic (Additional
file 1: Figure S4).
Genome-wide bioinformatic analyses showed that
when classified based on repeat length, the density of
minisatellites greater than 1 kb in length is highest in
the pericentromeric and subtelomeric regions. Con-
versely, VNTRs shorter than 1 kb in length are found to
cluster primarily away from the pericentromeric regions
(Additional file 1: Figure S8). PCR amplification of the
minisatellite located at 16q24.1 in the mother of patient
4 revealed that it is truncated (~2 kb) when compared to
the reference human genome (~8.6 kb). We suggest that
the smaller size of this minisatellite in the mother of
patient 4 might have undergone an incomplete hete-
rochromatinization, predisposing it to a higher rate of
DNA replication errors [38] and subsequent formation
of the complex rearrangement via break-induced replica-
tion (BIR) or microhomology-mediated break-induced
replication (MMBIR) [39,40]. We propose the microdu-
plication arose pre-meiotically, as a mitotic DNA repli-
cation error in the patient 4? s mother (Figure 4e). A
DNA replication slippage within the minisatellite led to
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invasion at chr16(-):86,978,360. A 2 bp GC microhomol-
ogy mediated another template switch in the reverse
direction from chr16(-):86,979,735 to chr16(+):87,102,896
and a 2 bp CA microhomology might have mediated
another template switch in the forward direction from
chr16(+):87,102,675 to chr16(+):87,168,469. This resulted
in a triplication of the segments chr16(+):87,102,675-
87,102,896 (221 bp) (yellow block) and chr16(-):86,978,
360-86,979,735 (1375 bp) (green block), in addition to
the duplication observed (Figure 4e). A high frequency
of small deletions and insertions, likely originating
from polymerase slippage events at breakpoint junc-
tions of complex copy-number variants, have recently
been reported in patients with MECP2 duplications
[41]. In addition, analyses of structural variation from
the first sequenced personal genome [42,43] showed
that minisatellites were responsible for 25.8% of
medium-sized (<10 kb) structural variants [44]. Inter-
estingly, intersection of VNTRs larger than 1 kb with
uncertain CNV breakpoint regions (between minimum
and maximum coordinates) smaller than 20 kb in size
identified in 16,886 patients from the CMA database of
39,729 patients analyzed at MGL, revealed 156 unique
CNVs, suggesting some of them might have also been
mediated by long minisatellites (Additional files 1 and 2:
Table S2).
Conclusions
In aggregate, we describe 16q24.1 duplications involving
FOXF1 in four unrelated families with speech delay, ID,
and gastrointestinal abnormalities. The lack of any pul-
monary symptoms in these patients suggests relatively
benign pediatric pulmonary consequences of FOXF1
overexpression due to constitutional duplications. Dis-
cerning the effects of FOXF1 overexpression or ectopic
expression is of primary importance for any future work
towards FOXF1-based gene therapies for ACDMPV and
other disorders caused by FOXF1 abnormal dosage.
Given the findings in family 3 and the fact that FOXF1
alterations were associated with intestinal abnormalities
[2,4,36,45], we propose that patients with gut malrota-
tion, pyloric or duodenal stenosis, or gall bladder agene-
sis should be tested for FOXF1 mutations and CNVs.
Moreover, our analyses revealed an evolutionarily un-
stable and highly polymorphic minisatellite in 16q24.1.
We propose that instability of minisatellites greater than
1 kb can lead to genomic structural variation due to
DNA replication errors.
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